Polyethylenimine Linear (PEI, MW 40,000): High-Efficiency Transfection Reagent for In Vitro Studies

Executive Summary: Polyethylenimine Linear (PEI, MW 40,000) is a cationic polymer widely applied as a DNA transfection reagent in molecular biology (APExBIO). It condenses negatively charged DNA, forming positively charged complexes that enhance endocytosis-mediated cellular uptake (Li et al., 2025). Typical transfection efficiencies range from 60% to 80% in cell lines such as HEK-293 and CHO-K1 under serum-containing conditions (internal summary). The reagent is scalable for both 96-well assays and 100-liter bioreactor applications. Storage at -20°C ensures long-term stability, with 2.5 mg/mL formulation available for versatile laboratory workflows.

Biological Rationale

Transfection is a core technique for introducing exogenous DNA or RNA into eukaryotic cells. High-efficiency delivery is essential for studies involving gene function, protein expression, and disease modeling. The cell membrane is negatively charged due to phospholipid head groups and proteoglycans, creating a barrier to anionic nucleic acids. Polyethylenimine Linear (PEI, MW 40,000) overcomes this by condensing DNA into cationic particles, which interact efficiently with the cell surface. Serum compatibility is critical for many cell lines, as serum deprivation can induce stress responses or apoptosis (internal). PEI’s compatibility with serum enables robust, reproducible results in both adherent and suspension cultures, facilitating applications from bench research to large-scale protein production.

Mechanism of Action of Polyethylenimine Linear (PEI, MW 40,000)

PEI is a synthetic polymer with repeating ethylenimine units, resulting in a high density of primary and secondary amines. At physiological pH (~7.4), these amines are protonated, imparting a strong positive charge. The mechanism involves:

• DNA Condensation: PEI binds and condenses negatively charged DNA via electrostatic interactions, forming nanoparticles of 100–200 nm diameter (internal).
• Cell Surface Binding: The cationic complexes interact with negatively charged cell surface glycosaminoglycans and proteoglycans, increasing binding affinity.
• Endocytosis: PEI/DNA complexes are internalized predominantly via clathrin-mediated and caveolae-mediated endocytosis (Li et al., 2025).
• Endosomal Escape: The "proton sponge" effect of PEI buffers endosomal acidification, causing osmotic swelling and rupture, releasing DNA into the cytoplasm.
• Nuclear Entry and Expression: During cell division, nuclear envelope breakdown facilitates DNA entry and subsequent transient gene expression.

This mechanism distinguishes linear PEI from branched forms and other transfection reagents, supporting its broad utility and reproducibility (internal).

Evidence & Benchmarks

• PEI-mediated transfection achieves 60–80% efficiency in HEK-293, CHO-K1, and HeLa cells under serum-containing conditions (Li et al., 2025).
• DNA/PEI complexes of 100–200 nm diameter maximize uptake while minimizing cytotoxicity (internal).
• Scalable performance documented from 96-well plates (~0.1–1 mL) to 100-liter bioreactors for protein production (internal).
• PEI supports transient gene expression in a range of mammalian cells, enabling rapid recombinant protein yield in under 72 hours (internal).
• Endocytosis-mediated uptake is validated for both DNA and emerging mRNA nanoparticle approaches (internal).

Applications, Limits & Misconceptions

Polyethylenimine Linear (PEI, MW 40,000) is routinely used for:

• Transient transfection in HEK-293, HEK293T, CHO-K1, HepG2, and HeLa cells.
• Recombinant protein production in research and preclinical development.
• Functional genomics, CRISPR/Cas9 delivery, and reporter assays (product page).
• Scalable workflows from 96-well formats to 100-liter bioreactor runs.
• Serum-compatible protocols, supporting sensitive and primary cell lines (internal).

This article extends the mechanistic and application scope described in Polyethylenimine Linear (PEI MW 40,000): Precision DNA Tr... by deepening the focus on endocytosis pathways and benchmarking across cell types.

Common Pitfalls or Misconceptions

• Not suitable for in vivo delivery: PEI is primarily validated for in vitro use due to non-specific toxicity in animal models.
• Branched vs. Linear PEI: Only linear PEI with MW 40,000 confers the high efficiency and low toxicity described; branched or lower/higher MW forms may differ substantially (internal).
• Repeated freeze-thaw cycles: Degrade PEI activity; store at -20°C for stability, or at 4°C for frequent use, avoiding cycles.
• No compatibility with all cell types: Some primary or sensitive cells may require optimization or may not tolerate PEI well.
• Overloading DNA or PEI: High DNA:PEI ratios increase cytotoxicity and decrease transfection efficiency.

Workflow Integration & Parameters

For optimal use of Polyethylenimine Linear (PEI, MW 40,000) (K1029 kit, APExBIO), practitioners should:

• Prepare PEI/DNA complexes at an N/P ratio (nitrogen in PEI to phosphate in DNA) of 10:1 to 20:1 for most cell lines.
• Dilute PEI and DNA in sterile, serum-free buffer (e.g., 150 mM NaCl or HEPES-buffered saline) before mixing.
• Incubate complexes for 15–20 minutes at room temperature before adding to cells.
• Apply to cells in serum-containing medium unless protocol specifies otherwise.
• Monitor expression at 24–72 hours post-transfection; remove complexes after 4–6 hours if cytotoxicity is observed.
• Store stock solution (2.5 mg/mL) at -20°C long-term, at 4°C for up to 1 month for frequent use; never refreeze/thaw repeatedly.

This article clarifies workflow parameters beyond the application-focused review in Innovations in Polyethylenimine Linear, emphasizing practical handling and troubleshooting tips.

Conclusion & Outlook

Polyethylenimine Linear (PEI, MW 40,000) remains a standard for high-efficiency, serum-compatible DNA transfection in molecular biology. Its robust, scalable performance accelerates transient gene expression and recombinant protein production workflows. APExBIO’s K1029 kit provides validated quality and consistency across research scales. Future innovations may further reduce cytotoxicity and expand compatibility with sensitive and primary cell types. This article updates prior reviews (internal) by incorporating recent mechanistic insight and benchmarking evidence for translational researchers.